Cargando…
A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
We set out to identify novel protein associations with potential as clinically viable biomarkers for bipolar disorder. To this end, we used proximity extension assay to analyze 201 unique proteins in blood serum from two independent cohorts comprising patients with bipolar disorder and healthy contr...
Autores principales: | Göteson, Andreas, Isgren, Anniella, Sparding, Timea, Holmén-Larsson, Jessica, Jakobsson, Joel, Pålsson, Erik, Landén, Mikael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826439/ https://www.ncbi.nlm.nih.gov/pubmed/35136035 http://dx.doi.org/10.1038/s41398-022-01819-y |
Ejemplares similares
-
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
por: Isgren, Anniella, et al.
Publicado: (2022) -
Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls
por: Zhang, Ruyue, et al.
Publicado: (2020) -
Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study
por: Sandberg, Johan V., et al.
Publicado: (2022) -
Personality traits in bipolar disorder and influence on outcome
por: Sparding, Timea, et al.
Publicado: (2017) -
Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter Study
por: Göteson, Andreas, et al.
Publicado: (2022)